trending Market Intelligence /marketintelligence/en/news-insights/trending/uTB_dx4np6r5oonuMXuP3g2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Momenta Pharmaceuticals upsizes offering to raise up to $258.7M

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Momenta Pharmaceuticals upsizes offering to raise up to $258.7M

Momenta Pharmaceuticals Inc. priced a common stock offering to raise about $225 million in gross proceeds.

The Cambridge, Mass.-based biotechnology company is selling 14,516,130 common shares at $15.50 apiece. Momenta has also granted underwriters a 30-day option to buy 2,177,419 additional shares for additional proceeds of about $33.7 million.

Goldman Sachs & Co. LLC and J.P. Morgan are joint lead book-running managers, while Stifel is a book-running manager for the offering.